251 related articles for article (PubMed ID: 25574839)
1. Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling.
Menéndez-Gutiérrez MP; Rőszer T; Fuentes L; Núñez V; Escolano A; Redondo JM; De Clerck N; Metzger D; Valledor AF; Ricote M
J Clin Invest; 2015 Feb; 125(2):809-23. PubMed ID: 25574839
[TBL] [Abstract][Full Text] [Related]
2. The multi-faceted role of retinoid X receptor in bone remodeling.
Menéndez-Gutiérrez MP; Ricote M
Cell Mol Life Sci; 2017 Jun; 74(12):2135-2149. PubMed ID: 28105491
[TBL] [Abstract][Full Text] [Related]
3. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
[TBL] [Abstract][Full Text] [Related]
4. Tributyltin induces distinct effects on cortical and trabecular bone in female C57Bl/6J mice.
Watt J; Baker AH; Meeks B; Pajevic PD; Morgan EF; Gerstenfeld LC; Schlezinger JJ
J Cell Physiol; 2018 Sep; 233(9):7007-7021. PubMed ID: 29380368
[TBL] [Abstract][Full Text] [Related]
5. Molecular determinants of the interactions between SRC-1 and LXR/RXR heterodimers.
Son YL; Lee YC
FEBS Lett; 2010 Sep; 584(18):3862-6. PubMed ID: 20682316
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide profiling of liver X receptor, retinoid X receptor, and peroxisome proliferator-activated receptor α in mouse liver reveals extensive sharing of binding sites.
Boergesen M; Pedersen TÅ; Gross B; van Heeringen SJ; Hagenbeek D; Bindesbøll C; Caron S; Lalloyer F; Steffensen KR; Nebb HI; Gustafsson JÅ; Stunnenberg HG; Staels B; Mandrup S
Mol Cell Biol; 2012 Feb; 32(4):852-67. PubMed ID: 22158963
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between RXR, LXR and VDR within blood mononuclear cellular model.
Dave VP; Kaul D; Sharma M
Indian J Exp Biol; 2012 Jan; 50(1):35-40. PubMed ID: 22279938
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TUG1 positively regulates osteoclast differentiation by targeting v-maf musculoaponeurotic fibrosarcoma oncogene homolog B.
Du YJ; Yu QQ; Zheng XF; Wang SP
Autoimmunity; 2020 Dec; 53(8):443-449. PubMed ID: 33146047
[TBL] [Abstract][Full Text] [Related]
9. MafB promotes atherosclerosis by inhibiting foam-cell apoptosis.
Hamada M; Nakamura M; Tran MT; Moriguchi T; Hong C; Ohsumi T; Dinh TT; Kusakabe M; Hattori M; Katsumata T; Arai S; Nakashima K; Kudo T; Kuroda E; Wu CH; Kao PH; Sakai M; Shimano H; Miyazaki T; Tontonoz P; Takahashi S
Nat Commun; 2014; 5():3147. PubMed ID: 24445679
[TBL] [Abstract][Full Text] [Related]
10. Liver X receptors orchestrate osteoblast/osteoclast crosstalk and counteract pathologic bone loss.
Kleyer A; Scholtysek C; Bottesch E; Hillienhof U; Beyer C; Distler JH; Tuckermann JP; Schett G; Krönke G
J Bone Miner Res; 2012 Dec; 27(12):2442-51. PubMed ID: 22806960
[TBL] [Abstract][Full Text] [Related]
11. Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter.
Yoshikawa T; Shimano H; Amemiya-Kudo M; Yahagi N; Hasty AH; Matsuzaka T; Okazaki H; Tamura Y; Iizuka Y; Ohashi K; Osuga J; Harada K; Gotoda T; Kimura S; Ishibashi S; Yamada N
Mol Cell Biol; 2001 May; 21(9):2991-3000. PubMed ID: 11287605
[TBL] [Abstract][Full Text] [Related]
12. Cxcl9l and Cxcr3.2 regulate recruitment of osteoclast progenitors to bone matrix in a medaka osteoporosis model.
Phan QT; Tan WH; Liu R; Sundaram S; Buettner A; Kneitz S; Cheong B; Vyas H; Mathavan S; Schartl M; Winkler C
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19276-19286. PubMed ID: 32719141
[TBL] [Abstract][Full Text] [Related]
13. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
14. The role of microRNAs in osteoclasts and osteoporosis.
Tang P; Xiong Q; Ge W; Zhang L
RNA Biol; 2014; 11(11):1355-63. PubMed ID: 25692234
[TBL] [Abstract][Full Text] [Related]
15. RXR heterodimers orchestrate transcriptional control of neurogenesis and cell fate specification.
Simandi Z; Horvath A; Cuaranta-Monroy I; Sauer S; Deleuze JF; Nagy L
Mol Cell Endocrinol; 2018 Aug; 471():51-62. PubMed ID: 28778663
[TBL] [Abstract][Full Text] [Related]
16. Retinoids synergized with insulin to induce Srebp-1c expression and activated its promoter via the two liver X receptor binding sites that mediate insulin action.
Li R; Chen W; Li Y; Zhang Y; Chen G
Biochem Biophys Res Commun; 2011 Mar; 406(2):268-72. PubMed ID: 21316346
[TBL] [Abstract][Full Text] [Related]
17. NR4A1 Regulates Motility of Osteoclast Precursors and Serves as Target for the Modulation of Systemic Bone Turnover.
Scholtysek C; Ipseiz N; Böhm C; Krishnacoumar B; Stenzel M; Czerwinski T; Palumbo-Zerr K; Rothe T; Weidner D; Klej A; Stoll C; Distler J; Tuckermann J; Herrmann M; Fabry B; Goldmann WH; Schett G; Krönke G
J Bone Miner Res; 2018 Nov; 33(11):2035-2047. PubMed ID: 29949664
[TBL] [Abstract][Full Text] [Related]
18. Activation of the liver X receptor-β potently inhibits osteoclastogenesis from lipopolysaccharide-exposed bone marrow-derived macrophages.
Robertson Remen KM; Lerner UH; Gustafsson JÅ; Andersson G
J Leukoc Biol; 2013 Jan; 93(1):71-82. PubMed ID: 23099324
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.
Cary RL; Waddell S; Racioppi L; Long F; Novack DV; Voor MJ; Sankar U
J Bone Miner Res; 2013 Jul; 28(7):1599-610. PubMed ID: 23408651
[TBL] [Abstract][Full Text] [Related]
20. Hepatic TRAP80 selectively regulates lipogenic activity of liver X receptor.
Kim GH; Oh GS; Yoon J; Lee GG; Lee KU; Kim SW
J Clin Invest; 2015 Jan; 125(1):183-93. PubMed ID: 25437875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
